On March 28, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors of Kymera Therapeutics, Inc., the Board appointed Felix J. Baker, Ph.D. to join the Board, effective March 28, 2024. Dr. Baker will serve as a Class II director until his term expires at the 2025 annual meeting of stockholders at which time he will stand for election by the Company?s stockholders. The Board determined that Dr. Baker is independent under the listing standards of Nasdaq.

Dr. Baker was also appointed to serve as the Lead Independent Director of the Board. The Board has not determined which, if any, committee or committees of the Board Dr. Baker will join. Dr. Baker is a managing member of the general partner of Baker Bros.

Advisors LP.